1. Home
  2. BIVI vs POLA Comparison

BIVI vs POLA Comparison

Compare BIVI & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • POLA
  • Stock Information
  • Founded
  • BIVI 2013
  • POLA 1979
  • Country
  • BIVI United States
  • POLA United States
  • Employees
  • BIVI N/A
  • POLA N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • BIVI Health Care
  • POLA Miscellaneous
  • Exchange
  • BIVI Nasdaq
  • POLA Nasdaq
  • Market Cap
  • BIVI 14.2M
  • POLA 11.5M
  • IPO Year
  • BIVI N/A
  • POLA 2016
  • Fundamental
  • Price
  • BIVI $1.50
  • POLA $3.42
  • Analyst Decision
  • BIVI
  • POLA
  • Analyst Count
  • BIVI 0
  • POLA 0
  • Target Price
  • BIVI N/A
  • POLA N/A
  • AVG Volume (30 Days)
  • BIVI 119.4K
  • POLA 883.0K
  • Earning Date
  • BIVI 11-11-2025
  • POLA 11-14-2025
  • Dividend Yield
  • BIVI N/A
  • POLA N/A
  • EPS Growth
  • BIVI N/A
  • POLA N/A
  • EPS
  • BIVI N/A
  • POLA N/A
  • Revenue
  • BIVI N/A
  • POLA $11,967,000.00
  • Revenue This Year
  • BIVI N/A
  • POLA N/A
  • Revenue Next Year
  • BIVI N/A
  • POLA N/A
  • P/E Ratio
  • BIVI N/A
  • POLA N/A
  • Revenue Growth
  • BIVI N/A
  • POLA 0.14
  • 52 Week Low
  • BIVI $1.42
  • POLA $1.53
  • 52 Week High
  • BIVI $38.50
  • POLA $5.75
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 29.30
  • POLA 44.43
  • Support Level
  • BIVI $1.83
  • POLA $3.48
  • Resistance Level
  • BIVI $1.80
  • POLA $4.25
  • Average True Range (ATR)
  • BIVI 0.10
  • POLA 0.44
  • MACD
  • BIVI -0.03
  • POLA -0.09
  • Stochastic Oscillator
  • BIVI 14.79
  • POLA 10.31

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: